• Fluorescein TSA Fluorescence System Kit Workflow

  2026-08-20

  Learn how to use the Fluorescein TSA Fluorescence System Kit to reveal weak protein and nucleic-acid signals in IHC, ICC, and ISH. A neuroscience case study shows how sensitive localization assays can support mechanistic work on transcranial K+-channelrhodopsin inhibition without confusing fluorescence intensity with functional efficacy.

• Fluorescein TSA Fluorescence System Kit Workflow

  2026-08-20

  The Fluorescein TSA Fluorescence System Kit adds localized, covalent fluorescein deposition to IHC, ICC, and ISH workflows when conventional fluorescence is too dim. This guide connects the technology to metastatic HNSCC research, showing how to optimize low-abundance target detection without confusing amplification with biological abundance.

• 2-NBDG Glucose Uptake Assay Kit for HCC

  2026-08-19

  Map transporter-dependent glucose uptake in hepatocellular carcinoma without radioactivity, then connect the phenotype to sorafenib response and ferroptosis biology. This practical workflow combines single-cell fluorescence, phloretin specificity controls, PI-based viability assessment, and scalable 96-well screening.

• GnRH Antagonist Design at Position 3

  2026-08-19

  Samant and colleagues examined how replacing the position 3 residue of degarelix with stereochemically distinct 3-(2-methoxy-5-pyridyl)-alanine affects GnRH receptor antagonism and in vivo duration. The D-configured analog retained strong in vitro activity, whereas the L-configured form was weaker; both compounds were short-acting in castrated male rats, separating receptor potency from prolonged biological action.

• Quizartinib Workflows for FLT3 Research

  2026-08-18

  Learn how Quizartinib (AC220) supports target-engagement assays, AML cell studies, resistance profiling, and translational xenograft workflows. Practical guidance covers compound handling, assay design, pathway confirmation, dosing interpretation, and troubleshooting.

• EdU Flow Cytometry Assay Kits (Cy5): Lab Guide

  2026-08-18

  This scenario-based guide explains how EdU Flow Cytometry Assay Kits (Cy5), SKU K1078, can improve S-phase DNA synthesis measurement, multiplexing, and interpretation in proliferation and cytotoxicity studies. It connects practical assay design with recent evidence linking epithelial cell-cycle disruption to diabetic foot ulcer biology.

• KLF4 Control of AgRP Isoforms in Mice

  2026-08-17

  This study identifies KLF4 as a positive transcriptional regulator of Agrp in mouse hypothalamic AgRP neurons and distinguishes the tissue-specific expression of three Agrp isoforms. Its conditional genetics, metabolic phenotyping, and GT1-7 cell experiments show that KLF4-dependent regulation increases energy expenditure in lean mice but is obscured during diet-induced obesity.

• Lipo3K Transfection Reagent for GBM Studies

  2026-08-17

  Build cleaner PXDN knockdown, LDHA rescue, and reporter workflows with a low-toxicity lipid transfection reagent. Lipo3K supports DNA, siRNA, mRNA, difficult cell models, and co-transfection designs without requiring routine medium replacement.

• Angiotensin I/II (1-5): RAS Workflow Guide

  2026-08-16

  Angiotensin I/II (1-5) supplies a defined Asp-Arg-Val-Tyr-Ile peptide fragment for controlled renin-angiotensin system research involving blood pressure regulation, vascular responses, and aldosterone release stimulation. It is suited to cardiovascular and renal physiology workflows, but its water insolubility, vehicle requirements, and limited product-specific evidence make it unsuitable as a general substitute for intact angiotensin peptides or unrelated signaling assays.

• RNA Pol II Inhibition and Apoptotic Signaling

  2026-08-15

  Harper et al. show that RNA polymerase II inhibition kills cells through an active apoptotic program rather than through passive loss of transcription, mRNA, or protein. Their functional-genomic and chemogenetic analyses define a Pol II degradation-dependent apoptotic response (PDAR) and suggest that this signaling mechanism contributes to the activity of diverse anticancer compounds.

• JZL184 Beyond MAGL: A Pain-Affect Assay Framework

  2026-08-14

  JZL184 is a selective monoacylglycerol lipase inhibitor for dissecting 2-AG, CB1, pain, and affective signaling. This guide presents an assay-centered framework that distinguishes enzyme, synaptic, sensory, and emotional endpoints.

• HyperFluor™ 488 Rabbit Anti-Goat IgG (H+L) Antibody

  2026-08-14

  Use this Alexa Fluor 488 conjugated secondary antibody to convert goat-primary immunoassays into sensitive, image-ready workflows across fluorescence microscopy, Western blotting, tissue staining, and flow cytometry. The article translates FXR-driven replication-organelle biology into practical assay design, controls, and troubleshooting decisions.

• iRhom2 Links Olfactory Receptors to Adaptation

  2026-08-13

  Azzopardi and colleagues identify iRhom2 as a distinctive component of olfactory sensory neurons and connect its expression with odorant receptor regulation and activity-dependent adaptation. Their combination of mouse genetics, transcriptomics, spatial analysis, and an ectopic receptor-signaling model supports an iRhom2/ADAM17 feedback mechanism, while also defining important limits on causal interpretation.

• Pazopanib Hydrochloride: Mechanism & Benchmarks

  2026-08-13

  Pazopanib Hydrochloride (GW786034) is a multi-target receptor tyrosine kinase inhibitor used in oncology research and approved clinical indications. This evidence-focused guide separates kinase potency, tumor-model activity, clinical scope, and viability-assay interpretation.

• Dasatinib and the SNAI1–EphA2 Translational Axis

  2026-08-12

  A translational framework for using Dasatinib (BMS-354825) to interrogate Src-linked signaling, EMT, stemness, and metastatic phenotypes emerging from the SNAI1–PIK3R2/p-EphA2 axis in thymic epithelial tumors.

15400 records 1/1027 page Next 12345 下5页 Last page